Showing results (151-160 of 235) with videos related to

Sort By:
Pageof 24
Annals of Clinical and Translational Neurology|July 29, 2026
Disease Course After Anti-CD20 Discontinuation in Secondary Progressive Multiple Sclerosis-A Multicenter Long-Term Longitudinal StudyFerdinand Otto, Dariia Kliushnikova, Richard Friedrich Radlberger, et al.
Environmental Pollution (Barking, Essex : 1987)|April 8, 2021
Effects of driving conditions on secondary aerosol formation from a GDI vehicle using an oxidation flow reactorNiina Kuittinen, Cavan McCaffery, Weihan Peng, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 12, 2018
Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of therapeutic liposomesAlexandros Papachristodoulou, Rea Deborah Signorell, Beat Werner, et al.
Plos One|November 21, 2024
Factors associated with low health-related quality of life in persons with multiple sclerosis: A quantile-based segmentation approachStefania Iaquinto, Benjamin Victor Ineichen, Anke Salmen, et al.
Oncotarget|February 18, 2016
MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIMNina Stojcheva, Gennadi Schechtmann, Steffen Sass, et al.
Physics in Medicine and Biology|December 22, 2018
Closed-loop cavitation control for focused ultrasound-mediated blood-brain barrier opening by long-circulating microbubblesMustafa Çavuşoğlu, Jia Zhang, Giovanna Diletta Ielacqua, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 8, 2022
Redefining Perineural Invasion in Head and Neck Cutaneous Squamous Cell CarcinomaErin R Cohen, Carly Misztal, Cortney Dable, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2020
MRI and 18FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE TrialHans-Georg Wirsching, Ulrich Roelcke, Jonathan Weller, et al.
Pageof 24